“Strong fundamentals and execution across our business, combined with innovative, integrated clinical and commercial capabilities enabled by data and technology, drove robust earnings and cash flow ...

Revenue for the first quarter of $1,356.8 million increased 1.5% on a reported basis and increased 2.4% on a constant currency basis year-over-year. Clinical Solutions net new business awards and book ...

Syneos Health stockholders approved the firm’s $7.1 billion sale to a consortium of private equity firms, the company said after a special meeting Wednesday. The group taking Syneos private consists ...

Syneos Health cemented a multi-year deal to use Microsoft’s platform for deploying artificial intelligence (AI) in its clinical trials and commercial programs. The agreement announced this week ...

Syneos Health, a leading biopharmaceutical contract research organization, agreed to be acquired for $7.1 billion by a group of private equity firms. Elliott Investment Management, Patient Square ...

Narrow-moat Syneos SYNH announced it will be acquired by a consortium of three private investment firms (Elliott Investment Management, Patient Square Capital, and Veritas Capital) for $43 per share ...

March 9 (Reuters) - Syneos Health Inc SYNH.O, a U.S. contract research organization (CRO) that serves the pharmaceutical industry, is exploring a sale, people familiar with the matter said on Monday.

Elligo Health Research has announced it is expanding its IntElligo Study Marketplace platform with Syneos Health. The platform aims to make sales, site selection and application processes more ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Triangle is now home to one ...

Syneos Health is a global provider of end-to-end biopharmaceutical outsourcing solutions. The Company operates through two ...

Narrow-moat Syneos SYNH reported fourth-quarter results largely in line with our expectations. Full-year revenue of nearly $5.4 billion represented a 3.5% increase from the prior year. The company ...

Syneos Health Inc.’s stock SYNH soared 9% in premarket trade Wednesday, after the biopharma services company said it has agreed to be acquired by a private investment consortium for about $7.1 billion ...